Skip to main content
. 2022 Feb 18;12:844182. doi: 10.3389/fonc.2022.844182

Table 1.

Baseline characteristics and imaging data stratified by gender.

Male (N=53) Female (N=168) P value
Age(years), mean ±SD 39.1±12.7 31.6±12.2 0.001
Symptoms, N% 0.251
 incidentally found 42(79.2) 116(69.0)
 abdominal pain 10(18.9) 30(17.9)
 abdominal distension 0(0) 12(7.1)
 nausea and vomiting 0(0) 8(4.8)
 jaundice 1(1.9) 2(1.2)
Surgical methods, N% 0.370
 PD 13(24.5) 48(28.6)
 DP 25(47.2) 82(48.8)
 CP 10(18.9) 28(16.7)
 TP 0(0) 10(6.0)
 enucleation 5(9.4) 8(4.8)
Hospital stays (days), mean ±SD 14.2±9.3 12.0±6.0 0.08
Tumor size (mm), mean ±SD 39.6±22.8 50.4±28.7 0.038
Tumor location (head/body/tail/ diffuse), N% 23/5/4/21 67/19/19/63 0.92
Imaging diagnoses, N%
 SPN 28(54.0) 118(70.5) 0.02
 Malignant tumor 20(37.7) 18(10.7) <0.0001
 neuroendocrine tumor 1(1.9) 11(6.5) 0.192
 other benign tumors 4(7.5) 21(12.8) 0.321
Imaging diagnoses for having surgical indications, N% 49(92.5) 147(87.5) 0.519
Solid component, N%
 Completely solid 25(47.2) 40(23.8) 0.001
 Completely cystic 0(0) 32(19.0) <0.001
 >50% solid component 23(43.4) 55(32.7) 0.157
 <50% solid component 5(9.4) 41(24.4) 0.043
Average solid component proportion, % 66.8 24.7 <0.001

SD, standard deviation; SPN, Solid pseudopapillary neoplasm; PD, pancreatoduodenectomy; TP, total pancreatectomy; DP, distal pancreatectomy; CP, central pancreatectomy.